Targeted Therapy Pralsetinib Achieves High Response Rates in Advanced Cancers: Study - MY HEALTH TODAY

Breaking

Home Top Ad

Responsive Ads Here

Post Top Ad

Responsive Ads Here

Saturday, May 30, 2020

Targeted Therapy Pralsetinib Achieves High Response Rates in Advanced Cancers: Study

In patients with RET fusion-positive thyroid cancers, pralsetinib achieved an overall response rate (ORR), said clinical trial results.


from Medindia Health News https://ift.tt/36OGtKT
via

No comments:

Post a Comment

Post Bottom Ad

Responsive Ads Here

Pages